ArticleFrontiers in artificial intelligence2025
Artificial liver classifier: a new alternative to conventional machine learning models.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Supervised machine learning classifiers sometimes face challenges related to the performance, accuracy, or overfitting. Methods: This paper introduces the Artificial Liver Classifier (ALC), a novel supervised learning model inspired by the human liver's detoxification function. The ALC is characterized by its simplicity, speed, capability to reduce overfitting, and effectiveness in addressing multi-class classification problems through straightforward mathematical operations. To optimize the ALC's parameters, an improved FOX optimization algorithm (IFOX) is employed during training. Results: We evaluate the proposed ALC on five benchmark datasets: Iris Flower, Breast Cancer Wisconsin, Wine, Voice Gender, and MNIST. The results demonstrate competitive performance, with ALC achieving up to 100% accuracy on the Iris dataset-surpassing logistic regression, multilayer perceptron, and support vector machine-and 99.12% accuracy on the Breast Cancer dataset, outperforming XGBoost and logistic regression. Across all datasets, ALC consistently shows smaller generalization gaps and lower loss values compared to conventional classifiers. Discussion: These findings highlight the potential of biologically inspired models to develop efficient machine learning classifiers and open new avenues for innovation in the field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.